Literature DB >> 10325902

Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

P J Barnes1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10325902      PMCID： PMC1745439          DOI： 10.1136/thx.54.3.245

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  103 in total

Review 1.  Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema.

Authors:  R Mahadeva; D A Lomas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

2.  Haplotype associated with low interleukin-10 production in patients with severe asthma.

Authors:  S Lim; E Crawley; P Woo; P J Barnes
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

3.  DNA on a chip: serving up the genome for diagnostics and research.

Authors:  R W Wallace
Journal:  Mol Med Today       Date:  1997-09

4.  Sequence variant of the human cathepsin G gene.

Authors:  B Lüdecke; W Poller; K Olek; K Bartholomé
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

5.  Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Authors:  K H In; K Asano; D Beier; J Grobholz; P W Finn; E K Silverman; E S Silverman; T Collins; A R Fischer; T P Keith; K Serino; S W Kim; G T De Sanctis; C Yandava; A Pillari; P Rubin; J Kemp; E Israel; W Busse; D Ledford; J J Murray; A Segal; D Tinkleman; J M Drazen
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; J E Connett; R E Kanner; W W Lee; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

7.  Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis.

Authors:  P F Pignatti; C Bombieri; C Marigo; M Benetazzo; M Luisetti
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

8.  Risk factors associated with longitudinal change in pulmonary function.

Authors:  T H Beaty; H A Menkes; B H Cohen; C A Newill
Journal:  Am Rev Respir Dis       Date:  1984-05

9.  Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.

Authors:  J M Sallenave; J Shulmann; J Crossley; M Jordana; J Gauldie
Journal:  Am J Respir Cell Mol Biol       Date:  1994-12       Impact factor: 6.914

10.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205
View more
  22 in total

Review 1.  Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function.

Authors:  Y Chen
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  [New therapeutic approaches to COPD].

Authors:  M Pfeifer
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

Review 3.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

4.  Trachea epithelium as a "canary" for cigarette smoking-induced biologic phenotype of the small airway epithelium.

Authors:  Meredith L Turetz; Timothy P O'Connor; Ann E Tilley; Yael Strulovici-Barel; Jacqueline Salit; David Dang; Matthew Teater; Jason Mezey; Andrew G Clark; Ronald G Crystal
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

Review 5.  Therapeutic potential of growth factors in pulmonary emphysematous condition.

Authors:  Jai Prakash Muyal; Vandana Muyal; Sudhir Kotnala; Dhananjay Kumar; Harsh Bhardwaj
Journal:  Lung       Date:  2012-11-17       Impact factor: 2.584

6.  Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers.

Authors:  Matthaios Speletas; Vassiliki Merentiti; Konstantinos Kostikas; Kyriaki Liadaki; Markos Minas; Konstantinos Gourgoulianis; Anastasios E Germenis
Journal:  Clin Dev Immunol       Date:  2010-02-15

7.  Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.

Authors:  Kaouther Snoussi; Wijden Mahfoudh; Noureddine Bouaouina; Meriem Fekih; Hedi Khairi; Ahmed N Helal; Lotfi Chouchane
Journal:  BMC Cancer       Date:  2010-06-12       Impact factor: 4.430

8.  p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.

Authors:  Nivedita Tiwari; Amarnath S Marudamuthu; Yoshikazu Tsukasaki; Mitsuo Ikebe; Jian Fu; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

Review 9.  alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

Authors:  R A Sandhaus
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

10.  Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and severity.

Authors:  K Schwabe; G Vacca; R Dück; A Gillissen
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.